Skip to main content
. 2018 May 15;9:481. doi: 10.3389/fphar.2018.00481

Figure 1.

Figure 1

Dose response curves of BetA. (A) Cytotoxicity of BetA toward drug-sensitive parental CCRF-CEM tumor cells and their P-glycoprotein (MDR1/ABCB1)-expressing, multidrug-resistant subline, CEM/ADR5000. (B) Cytotoxicity of BetA toward MDA-MB-231-pc DNA cells and their BCRP-transduced subline, MDA-MB-231-BCRP as determined by resazurin assays. (C) Cytotoxicity of BetA toward HEK293 cells and their ABCB5-transfectant subline, HEK293/ABCB5 as determined by resazurin assays. (D) Cytotoxicity of BetA U87MG cells and their EGFR- transduced subline U87MGΔEGFR, as determined by resazurin assays.